ASLAN Pharmaceuticals Net Tangible Assets

ASLAN Pharmaceuticals (ASLN) currently reports a net tangible assets of $-18M as of March 2024. That compares with $9.9M in the prior-year period — down 281.6% year over year. Use the charts on this page to explore ASLAN Pharmaceuticals's net tangible assets history and peer comparisons.

ASLAN Pharmaceuticals's net tangible assets decreased from $9.9M to $-18M — a 281.6% year-over-year decrease (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ASLAN Pharmaceuticals reported $-18M in net tangible assets as of March 2024. That compares with $9.9M in the prior-year period — down 281.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $-18M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ASLAN Pharmaceuticals, and consider following ASLN for alerts when major investors trade the stock.

ASLAN Pharmaceuticals is classified in the Healthcare sector. On net tangible assets, it currently shows $-18M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ASLN with unrelated industries.